Completed

Activity Monitoring Assessment of Opiate Withdrawal

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Morphine

Drug
Who is being recruted

Narcotic-Related Disorders+2

+ Mental Disorders

+ Substance-Related Disorders

From 21 to 55 Years
See all eligibility criteria
How is the trial designed

Treatment Study

Phase 2
Interventional
Study Start: September 1995
See protocol details

Summary

Principal SponsorNational Institute on Drug Abuse (NIDA)
Last updated: January 31, 2017
Sourced from a government-validated database.Claim as a partner

Study start date: September 30, 1995

Actual date on which the first participant was enrolled.

The purpose of this study is to determine if hyperactivity accompanies abrupt opiate withdrawal in heroin addicts, to determine if computerized solid state activity monitors are capable of quantifying hyperactivity, and to quantify the physical and affective symptoms occurring during abrupt withdrawal in heroin addicts and morphine's capacity to alleviate these symptoms.

NCT00000335
Principal SponsorNational Institute on Drug Abuse (NIDA)
Last updated: January 31, 2017
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Male

Biological sex of participants that are eligible to enroll.

From 21 to 55 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Narcotic-Related DisordersMental DisordersSubstance-Related DisordersChemically-Induced DisordersOpioid-Related Disorders

Criteria

Please contact site for information.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Washington DC VA

Washington D.C., United StatesOpen Washington DC VA in Google Maps
CompletedOne Study Center